Effect of the Nasal Gel "Nascum®-Plus" on Allergic Symptoms

Summary

The aim of this study is to assess if a physical barrier, created by the nasal gel Nascum®- Plus, is able to prevent or minimize the induction of nasal symptoms during allergen challenge in the Fraunhofer Allergen Challenge Chamber (ACC). Furthermore, the effect on soluble and cellular inflammatory markers induced by the allergic reaction will be assessed. Nascum®-Plus contains no active pharmaceutical ingredient, only monographed pharmaceutical excipients.

Timeline

Start

2018-12-12

Primary completion

2019-02-01

Completion

2019-02-01

Drugs

Indications